Cargando…

Skeletal muscle secretome in Duchenne muscular dystrophy: a pivotal anti-inflammatory role of adiponectin

BACKGROUND: Persistent inflammation exacerbates the progression of Duchenne muscular dystrophy (DMD). The hormone, adiponectin (ApN), which is decreased in the metabolic syndrome, exhibits anti-inflammatory properties on skeletal muscle and alleviates the dystrophic phenotype of mdx mice. Here, we i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lecompte, S., Abou-Samra, M., Boursereau, R., Noel, L., Brichard, S. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487898/ https://www.ncbi.nlm.nih.gov/pubmed/28188344 http://dx.doi.org/10.1007/s00018-017-2465-5

Ejemplares similares

Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy
por: Boursereau, Raphaël, et al.
Publicado: (2018)

AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy
por: Abou‐Samra, Michel, et al.
Publicado: (2020)

New targets to alleviate skeletal muscle inflammation: role of microRNAs regulated by adiponectin
por: Boursereau, Raphaël, et al.
Publicado: (2017)

Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy
por: Dubuisson, Nicolas, et al.
Publicado: (2022)

Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy
por: Dubuisson, Nicolas, et al.
Publicado: (2022)

Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors
por: Miyatake, Shouta, et al.
Publicado: (2016)

Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?
por: Abou-Samra, Michel, et al.
Publicado: (2020)

Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy—Implications for Therapies
por: Heydemann, Ahlke
Publicado: (2018)

Involvement of adiponectin in the pathogenesis of dystrophinopathy
por: Abou-Samra, Michel, et al.
Publicado: (2015)

Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy
por: Russell, Alan J., et al.
Publicado: (2023)

The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy
por: Dubinin, Mikhail V., et al.
Publicado: (2020)

Inflammasome Activity in the Skeletal Muscle and Heart of Rodent Models for Duchenne Muscular Dystrophy
por: Onódi, Zsófia, et al.
Publicado: (2023)

The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy
por: Hildyard, John C.W., et al.
Publicado: (2022)

Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne Muscular Dystrophy
por: Galindo, Cristi L., et al.
Publicado: (2015)

Cytokines and Chemokines as Regulators of Skeletal Muscle Inflammation: Presenting the Case of Duchenne Muscular Dystrophy
por: De Paepe, Boel, et al.
Publicado: (2013)

Medical management of muscle weakness in Duchenne muscular dystrophy
por: Rivera, Sarah R., et al.
Publicado: (2020)

Skeletal disproportion in glucocorticoid-treated boys with Duchenne muscular dystrophy
por: Kao, Kung-Ting, et al.
Publicado: (2019)

Functional muscle ischemia in Duchenne and Becker muscular dystrophy
por: Thomas, Gail D.
Publicado: (2013)

Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy
por: Barnard, Alison M., et al.
Publicado: (2018)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Anti-Inflammatory and General Glucocorticoid Physiology in Skeletal Muscles Affected by Duchenne Muscular Dystrophy: Exploration of Steroid-Sparing Agents
por: Herbelet, Sandrine, et al.
Publicado: (2020)

Skeletal Muscle Homeostasis in Duchenne Muscular Dystrophy: Modulating Autophagy as a Promising Therapeutic Strategy
por: De Palma, Clara, et al.
Publicado: (2014)

Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy
por: Rybalka, Emma, et al.
Publicado: (2015)

The Effect of Vitamin D Supplementation on Skeletal Muscle in the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Debruin, Danielle A., et al.
Publicado: (2019)

Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients
por: Etienne, Jessy, et al.
Publicado: (2020)

Strategies for Bottlenecks of rAAV-Mediated Expression in Skeletal and Cardiac Muscle of Duchenne Muscular Dystrophy
por: Li, Na, et al.
Publicado: (2022)

LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model
por: Boccanegra, Brigida, et al.
Publicado: (2023)

Duchenne muscular dystrophy disease severity impacts skeletal muscle progenitor cells systemic delivery
por: Saleh, Kholoud K., et al.
Publicado: (2023)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
por: Capitanio, Daniele, et al.
Publicado: (2020)

Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy
por: Ropars, Juliette, et al.
Publicado: (2016)

Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy
por: Godi, Claudia, et al.
Publicado: (2016)

Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy
por: Rugowska, Anna, et al.
Publicado: (2021)

Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022)

The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy
por: Merckx, Caroline, et al.
Publicado: (2022)

Using MRI to quantify skeletal muscle pathology in Duchenne muscular dystrophy: A systematic mapping review
por: Alic, Lejla, et al.
Publicado: (2021)

Carrier Woman of Duchenne Muscular Dystrophy Mimicking Inflammatory Myositis
por: Yoon, Jiyeol, et al.
Publicado: (2011)

Spatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24–month follow-up
por: Hooijmans, M. T., et al.
Publicado: (2017)

Muscle architecture is associated with muscle fat replacement in Duchenne and Becker muscular dystrophies
por: Veeger, Thom T. J., et al.
Publicado: (2021)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_rp9de2mbq1h6p2mg26q4u2n7d0